ICON Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call and Acknowledges Receipt of Deficiency Notice from Nasdaq

Contributed by: Business Wire

Logo

Tags

Research

Medical Devices

Finance

Clinical Trials

Professional Services

Biotechnology

Pharmaceutical

Health

Science

Other Science

ICON plc

More Like This

ICON plc Schedules First Quarter 2025 Earnings Conference Call

ICON plc Schedules Third Quarter 2024 Earnings Conference Call

ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices

ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results

ICON Hosts Investor Day and Updates Full Year 2024 Financial Guidance

ICON Issues Financial Guidance for Full Year 2024

ICON Reports First Quarter 2025 Results

ICON Reports Third Quarter 2025 Results